Technical Analysis for MDCO - The Medicines Company

Grade Last Price % Change Price Change
grade A 32.99 -0.33% -0.11
MDCO closed down 0.33 percent on Friday, May 17, 2019, on 72 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MDCO trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.33%
Up 3 Days in a Row Strength -0.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.71%
Outside Day Range Expansion 2.71%
Inside Day Range Contraction 4.70%
Overbought Stochastic Strength 4.70%

Older signals for MDCO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, as well as for use in patients undergoing percutaneous coronary intervention; Recothrom, a human recombinant thrombin used as an aid to hemostasis; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and ready-to-use formulation of Argatroban for the treatment of thrombosis. Its products under development include Cangrelor, an intravenous small molecule antiplatelet agent that is Phase III clinical trial for the prevention of platelet activation and aggregation; Oritavancin, an investigational intravenous antibiotic, which is in Phase III clinical trial for the treatment of acute bacterial skin and skin structure infections; and IONSYS, a pre-registration stage product for the short-term management of acute postoperative pain. The company's products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS); MDCO-216, a novel biologic product that is in Phase I trial to reverse atherosclerotic plaque development and reduce the risk of coronary events in patients with ACS; and ALN-PCS, a development program, which is in Phase I trial for the treatment of hypercholesterolemia. In addition, it offers acute care generic products for use in the cardiovascular, neurocritical care, and serious infection therapeutic areas; and promotes BRILINTA, an oral tablet antiplatelet medicine. The company has collaboration agreements with Alnylam Pharmaceuticals, Inc. and AstraZeneca LP. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.
Pain Chemical Compounds Organic Compounds Infection Skin And Skin Structure Infections Thrombosis Hypercholesterolemia Medical Emergencies Acute Coronary Syndrome Direct Thrombin Inhibitors Organochlorides Percutaneous Transluminal Coronary Angioplasty Thioethers
Is MDCO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.57
52 Week Low 16.69
Average Volume 938,144
200-Day Moving Average 27.3934
50-Day Moving Average 29.1298
20-Day Moving Average 31.336
10-Day Moving Average 31.913
Average True Range 1.2313
ADX 29.34
+DI 26.8633
-DI 11.5147
Chandelier Exit (Long, 3 ATRs ) 30.2761
Chandelier Exit (Short, 3 ATRs ) 30.6239
Upper Bollinger Band 33.7043
Lower Bollinger Band 28.9677
Percent B (%b) 0.85
BandWidth 15.115522
MACD Line 1.0374
MACD Signal Line 1.016
MACD Histogram 0.0214
Fundamentals Value
Market Cap 2.38 Billion
Num Shares 72.1 Million
EPS -10.00
Price-to-Earnings (P/E) Ratio -3.30
Price-to-Sales 20.03
Price-to-Book 14.81
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.78
Resistance 3 (R3) 34.90 34.44 34.48
Resistance 2 (R2) 34.44 33.98 34.37 34.38
Resistance 1 (R1) 33.71 33.70 34.08 33.59 34.28
Pivot Point 33.25 33.25 33.43 33.18 33.25
Support 1 (S1) 32.52 32.79 32.89 32.40 31.70
Support 2 (S2) 32.06 32.51 31.99 31.60
Support 3 (S3) 31.33 32.06 31.50
Support 4 (S4) 31.21